Factors influencing patient survival and renal function outcome in pulmonary-renal syndrome associated with ANCA (+) vasculitis: A single-center experience

Journal of Nephrology

Volumn 18, Issue 1, 2005, Pages 35-44

  Stangou, Maria ^a,b   Asimaki, Afroditi ^a   Bamichas, Gerasimos ^a   Christidou, Fotini ^a   Zoumbaridis, Nikolaos ^a   Natse, Taisir ^a   Galanis, Nikolaos ^a   Christaki, Pandora ^a   Patakas, Dimitrios ^a   Sombolos, Kostas ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b NONE   (Greece)

Author keywords

ANCA; Pulmonary renal syndrome; Survival

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; STEROID; IMMUNOSUPPRESSIVE AGENT; MYELOBLASTIN; PEROXIDASE; SERINE PROTEINASE;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DRUG SUBSTITUTION; FEMALE; FOLLOW UP; HUMAN; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; LUNG DISEASE; MALE; MORTALITY; OUTCOMES RESEARCH; PROTEINURIA; PULMONARY RENAL SYNDROME; REGRESSION ANALYSIS; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; SEPSIS; SMALL VESSEL VASCULITIS; SURVIVAL RATE; TREATMENT OUTCOME; BLOOD; COMPUTER ASSISTED TOMOGRAPHY; IMMUNOLOGY; KIDNEY; KIDNEY DISEASE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RADIOGRAPHY; SURVIVAL; SYNDROME; THORAX RADIOGRAPHY; VASCULITIS;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY DISEASES; LUNG DISEASES; MALE; MIDDLE AGED; MYELOBLASTIN; PEROXIDASE; RADIOGRAPHY, THORACIC; RETROSPECTIVE STUDIES; SERINE ENDOPEPTIDASES; SURVIVAL ANALYSIS; SYNDROME; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VASCULITIS;

EID: 16844367504     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Jennette JC, Falk RJ, Andrassy K. Nomenclature of systemic vasculitis. Proposal of an international consensus conference. Arthritis Rheum 1994, 37: 187-92.
2. Jennette JC, Falk RJ. Antineutrophil cytoplasmic antibodies and associated diseases: A review. Am J Kidney Dis 1990, 18: 188-95.
3. Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med 1997; 337:1512-23.
4. Ter Maaten JC, Fransen CF, Gans RO, Strack van Schijndel RJ, Hoorntje SJ. Respiratory failure in ANCA-associated vasculitis. Chest 1996; 110: 357-63.
5. Rodriguez W, Hanania N, Guy E, Guntupali J. Pulmonary-renal syndromes in the intensive care unit. Crit Care Clin 2002; 18: 881-95.
6. Falk RJ, Hogan S, Carey TS, Jennette JC. Glomerular disease collaborative network: clinical course of antineutrophil cytoplasmic antibody associated glomerulonephritis and systemic vasculitis. Ann Intern Med 1990; 113: 656-63.
7. Kamesh L, Harper L, Savage CO. ANCA-positive vasculitis. J Am Soc Nephrol 2002; 13: 1953-60.
8. Gallagher H, Kwan J, Jayne D. Pulmonary renal syndrome: a 4-year, single-center experience. Am J Kidney Dis 2002; 39: 42-7.
9. Goldschmeding R, Tervaert JW, Gans RO, Dolman KM, van den Ende ME, Kuizinga MC, Kallenberg CG, von dem Borne AE. Different immunological specificities and disease associations of c-ANCA and p-ANCA. Neth J Med 1990; 36: 114-6.
10. Franssen CF, Gans RO, Arends B, Hageluken C, ter Wee PM, Gerlag PG, Hoorntje SJ. Differences between anti-myeloperoxidase and anti-proteinase 3 associated renal disease. Kidney Int 1995; 45: 193-9.
11. Gal AA, Salinas FF, Staton GW. The clinical and pathological spectrum of ANCA related pulmonary disease: a comparison between perinuclear and cytoplasmic antineutrophil cytoplasmic antibodies. Arch Pathol Lab Med 1994; 118: 1209-14.
12. Akira M. Computed tomography and pathological findings in fulminant forms in idiopathic interstitial pneumonia. J Thorac Imaging 1999; 14: 76-84.
13. Davis AM, Johnson JE, Cruz-Gervis R. Is vasculitis an early pathogenic mechanism of interstitial pulmonary fibrosis? Chest 2001; 120.
14. Eschum G, Mink S, Sharma S. Pulmonary interstitial fibrosis as a presenting manifestation in perinuclear antineutrophil cytoplasmic antibody microscopic polyangiitis. Chest 2003; 123: 297-301.
15. Hiromura K, Nojima Y, Kitahara T, Ueki K, Maezawa A, Kawai H, Yano S, Naruse T. Four cases of anti-myeloperoxidase antibody related rapidly progressive glomerulonephritis during the course of idiopathic pulmonary fibrosis. Clin Nephrol 2000; 53: 384-9.
16. Kondoh Y, Taniguchi H, Kawabata Y, Yokoi T, Suzuki K, Takagi K. Acute exacerbation in idiopathic pulmonary fibrosis: analysis of clinical and pathological findings in three cases. Chest 1993; 103: 1808-12.
17. Vergunst CE, Van Gurp E, Hagen EC, van Houwelingen HC, Hauer HA, Noel LH, Waldherr R, Ferrario F, van der Woude FJ, Bruijn JA, Bajema IM. An index for renal failure in ANCA associated glomerulonephritis. Am J Kidney Dis 2003; 41: 532-8.
18. Haworth SJ, Savage CO, Carr D, Hughes JM, Rees AJ. Pulmonary hemorrhage complicating Wegener's granulomatosis and microscopic polyarteritis. BMJ 1985; 290: 1775-8.
19. Lauque D, Cadranel J, Lazor R, Pourrat J, Ronco P, Guillevin L, Cordier JF. Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Medicine 2000; 79: 222-33.
20. Cordier JF. A lung biopsy is unnecessary in the management of ANCA-positive patients with chest roentgenographic abnormalities. Sarcoidosis Vasc Diffuse Lung Dis 1996; 13: 235-7.
21. Slot MC, Tervaert JW, Franssen CF, Stegeman CA. Renal survival and prognostic factors in patients with PR3 ANCA associated vasculitis with renal involvement. Kidney Int 2003; 63: 670-7.
22. Apel FB, Gee B, Kashgarian M, Hayslett JP. Wegener's granulomatosis: clinical-pathologic correlations and long-term course. Am J Kidney Dis 1981; 1: 27-37.
23. Vizjak A, Rott T, Koselj-Kajtna M, Rozman B, Kaplan-Pavlovcic S, Ferluda D. Histologic and immunohistologic study and clinical presentation of ANCA- associated glomerulonephritis with correlation to ANCA antigen specificity. Am J Kidney Dis 2003; 41: 539-49.
24. Heilman RL, Offord KP, Holley KE, Velosa JA. Analysis of risk factors for patient and renal survival in crescentic glomerulonephritis. Am J Kidney Dis 1987; 9: 98-107.
25. Franssen CF, Stegeman CA, Oost-Kort CA, Kallenberg CG, Limburg PC, Tiebosch A, Dejong PE, Tervaert JW. Determinants of renal outcome in anti-myeloperoxidase associated necrotizing crescentic glomerulonephritis. J Am Soc Nephrol 1998; 9: 1915-23.
26. Remuzzi G, Bertani T. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 1990; 38: 384-94.
27. Cohen BA, Clark WF. Pauci-immune renal vasculitis: natural history, prognostic factors and impact of therapy. Am J Kidney Dis 2000; 36: 914-24.
28. Zauner I, Bach D, Braun N, Kramer BK, Funfstuck R, Helmchen U, Schollmeyer P, Bohler J. Predictive value of initial histology and effect of plasmapheresis on long-term prognosis of rapidly progressive glomerulonephritis. Am J Kidney Dis 2002; 39: 28-35.
29. Kapitsinou P, Ioannidis J, Boletis J, Sotsiou F, Nakopoulou L, Daphnis E, Moutsopoulos HM. Clinicopathologic predictors of death and ESRD in patients with pauci-immune necrotizing glomerulonephritis. Am J Kidney Dis 2003; 41: 29-37.
30. Andrassy K, Erb A, Koberisch J, Waldherr R, Ritz E. Wegener's granulomatosis with renal involvement: patient survival and correlations between initial renal function, renal histology, therapy and renal outcome. Clin Nephrol 1991; 35: 139-47.
31. Bajema IM, Hagen EC, Hermans J, Noel LH, Waldherr R, Ferrario F, Van Der Woude FJ, Bruijn JA. Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int 1999; 56: 1751-8.
32. Fauci AS, Woiff SM. Wegener's granulomatosis: studies in eighteen patients and review of the literature. Medicine 1973; 52: 536-61.
33. Westman KW, Bygman PG, Olson H, Ranstain J, Wieslander J. Relapse rate, renal survival and cancer morbidity in patients with Wegener's granulomatosis and microscopic polyangitis with renal involvement. J Am Soc Nephrol 1998; 9: 842-52.
34. DeOliviera J, Gaskin G, Dash A, Rees AJ, Pusey CD. Relationship between disease activity and anti-neutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis. Am J Kidney Dis 1995; 25: 380-9.